PROCESS FOR PREPARING BRANCHED ALCOHOLS
    32.
    发明申请
    PROCESS FOR PREPARING BRANCHED ALCOHOLS 审中-公开
    制备分支体系的方法

    公开(公告)号:US20130281696A1

    公开(公告)日:2013-10-24

    申请号:US13864774

    申请日:2013-04-17

    Applicant: BASF SE

    Abstract: Process for preparing branched alcohols of the general formula (I) where the groups R1 are different or identical and selected from C2-C3-alkyl, linear or branched, using at least one alcohol of the formula (II) R1—CH2—CH2—OH  (II) in homogeneous phase in the presence of at least one base, wherein at least one Ru(II)-containing complex compound is used in which the Ru(II) has at least one ligand L1 which is at least bidentate, where at least one coordination site of L1 is a nitrogen atom.

    Abstract translation: 制备通式(I)的支链醇的方法,其中基团R1不同或相同且选自直链或支链的C 2 -C 3 - 烷基,使用至少一种式(II)的醇R 1 -CH 2 -CH 2 - OH(II)在至少一个碱的存在下在均相中,其中使用至少一种含Ru(II)的络合物,其中Ru(II)具有至少一个至少二齿配位体L1,其中 L1的至少一个配位部位是氮原子。

    Method for the isomerization of a 3-(Z)-unsaturated carboxylic acid to the 3-(E)-isomer

    公开(公告)号:US12172956B2

    公开(公告)日:2024-12-24

    申请号:US16969680

    申请日:2019-02-13

    Applicant: BASF SE

    Abstract: The present invention relates to a method for isomerizing a 3-(Z)-unsaturated carboxylic acid of the formula 1-Z or a salt thereof, wherein R2 is C1-C24-alkyl, C2-C24-alkenyl having 1, 2, 3 or more than 3 C—C double bonds, unsubstituted or substituted C5-C12-cycloalkyl, or unsubstituted or substituted aryl; R1 is hydrogen or has one of the definitions specified for R2; with the proviso that R2 has a higher priority than R1 in accordance with IUPAC; to give a 3-(E)-unsaturated carboxylic acid of the formula I-E or a salt thereof, wherein the isomerization of the compound of the formula 1-Z is effected in the presence of an anhydride of an organic acid and a base or in the presence of a ketene of formula CR11R12C(0), wherein R11 and R12 are as defined in the claims and in the specification and a base. In particular, the present invention relates to a method for preparing compositions with increased content of (3E,7E)-homofarnesylic acid starting from compositions comprising (3Z,7E)- and (3E,7E)-homofarnesylic acid.

Patent Agency Ranking